Compugen Ltd. Stock TEL AVIV STOCK EXCHANGE
Equities
CGEN
IL0010852080
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
798.3 ILa | +6.44% | -1.66% | +16.03% |
04:04pm | Compugen Names David Silberman CFO | MT |
03-08 | Truist Securities Adjusts Price Target on Compugen to $5 From $4, Maintains Buy Rating | MT |
Sales 2024 * | 37.9M 13.91B 51.57M | Sales 2025 * | 35.29M 12.95B 48.02M | Capitalization | 187M 68.69B 255M |
---|---|---|---|---|---|
Net income 2024 * | -13M -4.77B -17.69M | Net income 2025 * | -29M -10.65B -39.46M | EV / Sales 2024 * | 4.94 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 5.3 x |
P/E ratio 2024 * |
-16.1
x | P/E ratio 2025 * |
-7.74
x | Employees | 68 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.62% |
Latest transcript on Compugen Ltd.
1 day | +6.44% | ||
1 week | -1.66% | ||
Current month | +8.27% | ||
1 month | -1.42% | ||
3 months | -5.17% | ||
6 months | +254.80% | ||
Current year | +16.03% |
Managers | Title | Age | Since |
---|---|---|---|
Anat Cohen-Dayag
CEO | Chief Executive Officer | 57 | 01-12-31 |
Alberto Sessa
DFI | Director of Finance/CFO | 61 | 22-10-31 |
Eran Ophir
CTO | Chief Tech/Sci/R&D Officer | - | 14-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Sekhri
CHM | Chairman | 65 | 17-10-01 |
Sanford Zweifach
BRD | Director/Board Member | 68 | 18-06-10 |
Gilead Halevy
BRD | Director/Board Member | 57 | 18-06-10 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-15 | 798.3 | +6.44% | 111 306 |
24-05-12 | 750 | -4.01% | 43,581 |
24-05-09 | 781.3 | -3.76% | 78,599 |
24-05-08 | 811.8 | +2.31% | 111,277 |
24-05-07 | 793.5 | -1.37% | 105,748 |
Delayed Quote TEL AVIV STOCK EXCHANGE, May 15, 2024 at 10:25 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.50% | 49.18B | |
+0.80% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.73% | 26.09B | |
-22.83% | 18.71B | |
+8.21% | 13.26B | |
+32.42% | 12.32B | |
-1.28% | 11.99B |
- Stock Market
- Equities
- CGEN Stock
- CGEN Stock